ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135758 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135758; 2) Community: the network communities that were significantly associated with the response to NSC 135758; 3) Molecule: the relationships between components within communities and NSC 135758; 4) MDR: the compounds that were significantly associated with the NSC 135758.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0285477013888569 0.51596276
NSC 300289 Pinafide 0.0285477013888569 0.65121331
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0285477013888569 0.098255371
NSC 328410 Camptothecin Derivative 0.0285477013888569 0.6706405
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0285477013888569 0.34050529
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0285477013888569 0.68385603
NSC 606499 Camptothecin Derivative 0.0285477013888569 0.81718038
NSC 619030 Analog of CC-1065 0.0285477013888569 0.74554838
NSC 646140 Null 0.0285477013888569 0.22428074
NSC 672974 Null 0.0285477013888569 0.65277252
Total:49  Current:30    [First] [Prev] [Next] [Last]